Anke Klippel, PhD, is the Head of Translational Sciences Oncology and Associate Vice President at Eli Lilly and Company. They possess extensive experience in initiating and delivering successful pharmaceutical and biotechnology programs within Oncology, leading high-performing teams, and managing collaborations with multinational companies. Anke co-invented specialized short interfering RNA molecules currently in clinical trials and has a track record of directing pre-clinical research and translational strategies, supported by 55 publications and 14 issued patents. Anke holds a PhD in Biochemistry from Freie Universität Berlin and completed a postdoctoral fellowship at the University of California, San Francisco.
This person is not in any teams
This person is not in any offices